Global Wealth Management Investment Advisory, Inc. Prothena Corp Public LTD CO Transaction History

Global Wealth Management Investment Advisory, Inc.

$578 Million
Q3 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$9.93 - $13.47 $69 - $94	-7 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.73 - $13.74 $61 - $96	7 New	7 $0

Others Institutions Holding PRTA

# of Institutions

219

Shares Held

35M

Call Options Held

656K

Put Options Held

1.12M

Black Rock Inc. New York, NY

3.86M
Shares

$39.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.05M
Shares

$21 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

1.82M
Shares

$18.7 Million
0.27% of portfolio
Rubric Capital Management LP New York, NY

1.54M
Shares

$15.8 Million
0.25% of portfolio
Adar1 Capital Management, LLC Austin, TX

1.47M
Shares

$15.1 Million
1.35% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $481M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account